Cargando…

Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches

Prion diseases are associated with the conformational conversion of the physiological form of cellular prion protein (PrP(C)) to the pathogenic form, PrP(Sc). Compounds that inhibit this process by blocking conversion to the PrP(Sc) could provide useful anti-prion therapies. However, no suitable dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyeon, Jae Wook, Choi, Jiwon, Kim, Su Yeon, Govindaraj, Rajiv Gandhi, Jam Hwang, Kyu, Lee, Yeong Seon, An, Seong Soo A., Lee, Myung Koo, Joung, Jong Young, No, Kyoung Tai, Lee, Jeongmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598813/ https://www.ncbi.nlm.nih.gov/pubmed/26449325 http://dx.doi.org/10.1038/srep14944

Ejemplares similares

BMD42-2910, a Novel Benzoxazole Derivative, Shows a Potent Anti-prion Activity and Prolongs the Mean Survival in an Animal Model of Prion Disease
por: Hyeon, Jae Wook, et al.
Publicado: (2020)

Anti-Prion Screening for Acridine, Dextran, and Tannic Acid using Real Time–Quaking Induced Conversion: A Comparison with PrP(Sc)-Infected Cell Screening
por: Hyeon, Jae Wook, et al.
Publicado: (2017)

Prion Diseases as Transmissible Zoonotic Diseases
por: Lee, Jeongmin, et al.
Publicado: (2013)

Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratory
por: Hyeon, Jae Wook, et al.
Publicado: (2015)

A Recombinant 47-kDa Outer Membrane Protein Induces an Immune Response against Orientia tsutsugamushi Strain Boryong
por: Choi, Sangho, et al.
Publicado: (2017)

In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L
por: Basith, Shaherin, et al.
Publicado: (2011)

Recent applications of computational methods to allosteric drug discovery
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2023)

Radotinib Decreases Prion Propagation and Prolongs Survival Times in Models of Prion Disease
por: Choi, Yeong-Gon, et al.
Publicado: (2023)

Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation
por: Lee, Sol Moe, et al.
Publicado: (2014)

Sequence variations of the bovine prion protein gene (PRNP) in native Korean Hanwoo cattle
por: Choi, Sangho, et al.
Publicado: (2012)

Prion Mutations in Republic of Republic of Korea, China, and Japan
por: Kim, Dan Yeong, et al.
Publicado: (2022)

Whole-Genome Sequence of Borrelia garinii Strain 935T Isolated from Ixodes persulcatus in South Korea
por: Noh, Yoontae, et al.
Publicado: (2014)

Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2010)

Application of “omics” to Prion Biomarker Discovery
por: Huzarewich, Rhiannon L. C. H., et al.
Publicado: (2010)

Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders
por: Lee, Sol Moe, et al.
Publicado: (2016)

Comparative assessment of strategies to identify similar ligand-binding pockets in proteins
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2018)

Optimal Triage for COVID-19 Patients Under Limited Health Care Resources With a Parsimonious Machine Learning Prediction Model and Threshold Optimization Using Discrete-Event Simulation: Development Study
por: Kim, Jeongmin, et al.
Publicado: (2021)

Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT
por: Um, Jihye, et al.
Publicado: (2017)

Application of the fragment molecular orbital method to discover novel natural products for prion disease
por: Choi, Jiwon, et al.
Publicado: (2018)

Prion therapeutics: Lessons from the past
por: Shim, Kyu Hwan, et al.
Publicado: (2022)

iBCE-EL: A New Ensemble Learning Framework for Improved Linear B-Cell Epitope Prediction
por: Manavalan, Balachandran, et al.
Publicado: (2018)

Structure and dynamic behavior of Toll‐like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum
por: Durai, Prasannavenkatesh, et al.
Publicado: (2013)

eModel-BDB: a database of comparative structure models of drug-target interactions from the Binding Database
por: Naderi, Misagh, et al.
Publicado: (2018)

In silico drug combination discovery for personalized cancer therapy
por: Jeon, Minji, et al.
Publicado: (2018)

Discriminant analysis of prion sequences for prediction of susceptibility
por: Lee, Ji-Hae, et al.
Publicado: (2013)

THERPA v2: an update of a small molecule database related to prion protein regulation and prion disease progression
por: Lee, Sol Moe, et al.
Publicado: (2019)

In silico Characterization of Human Prion-Like Proteins: Beyond Neurological Diseases
por: Iglesias, Valentin, et al.
Publicado: (2019)

25 years of yeast prions: Symposium honouring the 25-year anniversary of Reed Wickner’s discovery of yeast prions
por: Shewmaker, Frank, et al.
Publicado: (2020)

An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment
por: Park, Sung Woon, et al.
Publicado: (2020)

Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery
por: Chernova, Tatiana A., et al.
Publicado: (2019)

Treatment of Prion Disease with Heterologous Prion Proteins
por: Skinner, Pamela J., et al.
Publicado: (2015)

Novel coronavirus 2019: in-silico vaccine design and drug discovery
por: Kumar, Amit, et al.
Publicado: (2020)

Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2011)

Discovery of GSK3β Inhibitors through In Silico Prediction-and-Experiment Cycling Strategy, and Biological Evaluation
por: Lee, Yuno, et al.
Publicado: (2022)

Combination of structure-based virtual screening, molecular docking and molecular dynamics approaches for the discovery of anti-prion fibril flavonoids
por: Jheng, Cheng-Ping, et al.
Publicado: (2023)

MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews
por: Yang, Jiwon, et al.
Publicado: (2023)

Changes in consumers’ awareness and interest in cosmetic products during the pandemic
por: Choi, Yeong-Hyeon, et al.
Publicado: (2022)

Mutant-selective topologic conversion facilitates selective degradation of a pathogenic prion isoform
por: Lee, Yumi, et al.
Publicado: (2019)

Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches
por: Hwang, Jayeong, et al.
Publicado: (2021)

Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases: Miniperspective
por: Ghaemmaghami, Sina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tjsbh4a4kd18j229jg91mbvgje